Literature DB >> 7083139

Nonanatomic prognostic factors in carcinoma of the lung: a multivariate analysis.

J L Pater, M Loeb.   

Abstract

Existing records of 651 patients with bronchogenic carcinoma registered at the Kingston Clinic of the Ontario Cancer Treatment and Research Foundation during the period between 1965-1974 were examined in order to determine the relationship to survival of the following four "nonanatomic" prognostic factors: symptomatic history, performance status, weight loss, and age. Even when stage, histologic factors, and treatment were taken into account, it was found that weight loss and performance status significantly affected survival. Age, however, was related to survival only when the treatment given to the patient was not considered. Symptomatic history was important in so far as it related to weight loss and performance status. These results are compared to those obtained in other series and the implications discussed.

Entities:  

Mesh:

Year:  1982        PMID: 7083139     DOI: 10.1002/1097-0142(19820715)50:2<326::aid-cncr2820500227>3.0.co;2-g

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  14 in total

1.  A practical prognostic index for inoperable non-small-cell lung cancer.

Authors:  T Wigren; H Oksanen; P Kellokumpu-Lehtinen
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

2.  Performance Status in Cancer: Not Broken, But Time for an Upgrade?

Authors:  Jessica M Scott; Guro Stene; Elisabeth Edvardsen; Lee W Jones
Journal:  J Clin Oncol       Date:  2020-06-25       Impact factor: 44.544

3.  A novel paradigm in the treatment of oligometastatic non-small cell lung cancer.

Authors:  Salma K Jabbour; Parima Daroui; Dirk Moore; Edward Licitra; Molly Gabel; Joseph Aisner
Journal:  J Thorac Dis       Date:  2011-03       Impact factor: 2.895

Review 4.  Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress.

Authors:  Laura A A Gilliam; Daret K St Clair
Journal:  Antioxid Redox Signal       Date:  2011-06-15       Impact factor: 8.401

5.  Survival among non-small cell lung cancer patients with poor performance status after first line chemotherapy.

Authors:  Ramzi G Salloum; Thomas J Smith; Gail A Jensen; Jennifer Elston Lafata
Journal:  Lung Cancer       Date:  2012-05-26       Impact factor: 5.705

6.  Chemotherapy Use, Performance Status, and Quality of Life at the End of Life.

Authors:  Holly G Prigerson; Yuhua Bao; Manish A Shah; M Elizabeth Paulk; Thomas W LeBlanc; Bryan J Schneider; Melissa M Garrido; M Carrington Reid; David A Berlin; Kerin B Adelson; Alfred I Neugut; Paul K Maciejewski
Journal:  JAMA Oncol       Date:  2015-09       Impact factor: 31.777

7.  Association of Early Palliative Care With Chemotherapy Intensity in Patients With Advanced Stage Lung Cancer: A National Cohort Study.

Authors:  Austin Lammers; Christopher G Slatore; Erik K Fromme; Kelly C Vranas; Donald R Sullivan
Journal:  J Thorac Oncol       Date:  2018-10-15       Impact factor: 15.609

Review 8.  Understanding cardiovascular injury after treatment for cancer: an overview of current uses and future directions of cardiovascular magnetic resonance.

Authors:  Sujethra Vasu; W Gregory Hundley
Journal:  J Cardiovasc Magn Reson       Date:  2013-07-31       Impact factor: 5.364

Review 9.  Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008.

Authors:  Ali Montazeri
Journal:  Health Qual Life Outcomes       Date:  2009-12-23       Impact factor: 3.186

10.  Measurement of mid-arm muscle circumference and prognosis in stage IV non-small cell lung cancer patients.

Authors:  Rafaela Festugatto Tartari; Jane Maria Ulbrich-Kulczynski; Antônio Fabiano Ferreira Filho
Journal:  Oncol Lett       Date:  2013-01-11       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.